Saliva Test May Identify Acute Sleep Deprivation
Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.
Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.
The new recommendations add blood-based testing and multi-target stool testing as options for average-risk adults starting at age 45.
Clinical results show high sensitivity for colorectal cancer relapse and ultra-low detection limits for lung cancer.
The Callisto Sample Prep System application is optimized for the PromethION platform to support whole genome sequencing workflows.
The tissue- and blood-based tests identify patients with specific gene mutations who may benefit from a combination therapy.